AC Immune (ACIU) vs Pyxis Oncology, Inc. (PYXS)
AC Immune and Pyxis Oncology, Inc. are both Biotechnology companies. AC Immune and Pyxis Oncology, Inc. are of similar size ($250.2M and $249.4M). Pyxis Oncology, Inc. has the higher net margin (0.00% vs −1,783.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, AC Immune leads on 6 and Pyxis Oncology, Inc. on 5.
Valuation
Profitability
| Metric | ACIU | PYXS | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 0.00% | 65.16% |
| Operating margin | (1,745.75%) | 0.00% | 0.00% |
| Net margin | (1,783.66%) | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | 0.00% | (179.10%) | (57.72%) |
| Return on assets | 0.00% | (99.62%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack